Clinical Outcomes and Treatment Strategies in Patients With Non-Carbapenemase-producing Carbapenem-Resistant Versus Carbapenem-Susceptible Enterobacterales Infections.

Ashita Debnath Kelly E PillingerAlysa J MartinDavid DobrzynskiAndrew CameronStephanie Shulder

Published in: The Annals of pharmacotherapy (2022)

Our study found no difference in clinical outcomes between nCP-CRE and CSE infections. Application of this study with future studies would help in determining optimal regimens for these infections.

Keyphrases

klebsiella pneumoniae
acinetobacter baumannii
gram negative
drug resistant
current status
case control